Skip to main content

Master of Public Health

Validating the total illness burden index for prostate cancer (TIBI-CaP) in men with castration-resistant prostate cancer: data from TRUMPET.

AUTHORS

Flanders SC , Kim J , Wilson S , Braziunas J , Greenfield S , Billimek J , Lechpammer S , Lin DW , Karsh L , Quinn DI , Shevrin D , Shore ND , Symanowski JT , Penson DF , . Future oncology (London, England). 2018 2 8; ().
  • NIHMSID: 101256629

ABSTRACT

To validate the total illness burden index for prostate cancer (TIBI-CaP) in castration-resistant prostate cancer (CRPC) patients.

To validate the total illness burden index for prostate cancer (TIBI-CaP) in castration-resistant prostate cancer (CRPC) patients.

Tags: